Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Drugmakers propose swift pandemic response benefiting poorer countries

Published 05/22/2022, 06:04 PM
Updated 05/22/2022, 06:15 PM
© Reuters. FILE PHOTO: Cool boxes are being transported by airplane at the Schiphol Airport as Air France-KLM's cargo operations are preparing a massive logistical operation carrying new vaccines and vaccine candidates for COVID-19 through Amsterdam's Schiphol Airpo

FRANKFURT (Reuters) - Global drugmakers are lobbying for wealthy nations to fund a supply mechanism that would secure vaccines for low-income countries without delay in case of a new pandemic, but said the proposal was contingent on free cross-border trade.

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said in a statement on Monday that global pandemic vaccine distribution needs to be put on a new footing because the world’s poorest countries were forced to wait for shots during the current pandemic.

"The industry is willing to reserve an allocation of real-time production for distribution to priority populations in lower income countries, as determined by health authorities during pandemics," said IFPMA director general Thomas Cueni.

The global debate on a better response to disease outbreaks is in full swing as health ministers will meet in Geneva this week for the World Health Organization's assembly, with vaccine-sharing among the many agenda items.

Separately, the G20 group of nations has agreed to a multi-billion dollar fund for pandemic preparedness that will be set up outside the WHO.

Cueni added the procurement mechanism needed funding by higher-income countries and could only work if materials and finished products can be shipped without barriers within a globalised supply chain.

"We are committed to working with governments and all stakeholders to help ensure that preparedness systems are put in place and maintained into the future," said Cueni.

Trade barriers posed a big headache during the COVID-19 pandemic, now in its third year. Among the hurdles, key producer India banned vaccine exports for much of 2021, while the U.S. Defense Production Act, which prioritises the domestic crisis response, slowed global delivery of equipment for vaccine makers.

© Reuters. FILE PHOTO: Cool boxes are being transported by airplane at the Schiphol Airport as Air France-KLM's cargo operations are preparing a massive logistical operation carrying new vaccines and vaccine candidates for COVID-19 through Amsterdam's Schiphol Airport, Netherlands November 25, 2020. Picture taken November 25, 2020. REUTERS/Piroschka van de Wouw

The COVAX vaccine-sharing facility was set up to secure distribution in poorer countries but it was overtaken by wealthier nations' faster procurement efforts, leaving other countries behind.

"COVAX was not sufficiently funded or organised quickly enough to secure advance purchase agreements for doses on a par with high-income country purchasers," lobby group IFPMA said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.